A Single-Center Analysis of the Treatment and Prognosis of Patients With Thymic Carcinoma Yirui Zhai, MD, Zhouguang Hui, MD, Wei Ji, MD, Xiaozhen Wang, MD, Jun Liang, MD, Yousheng Mao, MD, Yang Luo, MD, Shuangmei Zou, MD, Jima Lv, MD, Zongmei Zhou, MD, Dongfu Chen, MD, Hongxing Zhang, MD, Zefen Xiao, MD, Luhua Wang, MD, Qinfu Feng, MD The Annals of Thoracic Surgery Volume 104, Issue 5, Pages 1718-1724 (November 2017) DOI: 10.1016/j.athoracsur.2017.06.025 Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 (a) Local-regional relapse free survival (LRFS), (b) overall survival (OS), (c) progression-free survival (PFS), and (d) distant metastasis–free survival (DMFS). The Annals of Thoracic Surgery 2017 104, 1718-1724DOI: (10.1016/j.athoracsur.2017.06.025) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 (a) Eastern Cooperative Oncology Group performance status (ECOG PS) and overall survival (OS), (b) Masaoka stage and OS, and (c) R0 resection and OS. The Annals of Thoracic Surgery 2017 104, 1718-1724DOI: (10.1016/j.athoracsur.2017.06.025) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 (a) Masaoka stage and progression-free survival (PFS), and (b) R0 resection and PFS. The Annals of Thoracic Surgery 2017 104, 1718-1724DOI: (10.1016/j.athoracsur.2017.06.025) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 4 (a) Masaoka stage and distant metastasis–free survival (DMFS), and (b) R0 resection and DMFS. The Annals of Thoracic Surgery 2017 104, 1718-1724DOI: (10.1016/j.athoracsur.2017.06.025) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions